Milan - Delayed Quote EUR

Garofalo Health Care S.p.A. (GHC.MI)

Compare
5.08
+0.13
+(2.63%)
At close: January 17 at 5:35:20 PM GMT+1
Loading Chart for GHC.MI
DELL
  • Previous Close 4.95
  • Open 4.97
  • Bid 5.04 x --
  • Ask 5.10 x --
  • Day's Range 4.94 - 5.10
  • 52 Week Range 4.43 - 5.92
  • Volume 19,659
  • Avg. Volume 35,030
  • Market Cap (intraday) 449.281M
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 28.22
  • EPS (TTM) 0.18
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 6.50

Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. It also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers. Garofalo Health Care S.p.A. was founded in 2000 and is based in Rome, Italy. Garofalo Health Care S.p.A. is a subsidiary of Larama 98 S.p.A.

www.garofalohealthcare.com

2,770

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GHC.MI

View More

Performance Overview: GHC.MI

Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

GHC.MI
6.96%
FTSE MIB Index
6.09%

1-Year Return

GHC.MI
12.89%
FTSE MIB Index
19.55%

3-Year Return

GHC.MI
0.39%
FTSE MIB Index
31.67%

5-Year Return

GHC.MI
12.26%
FTSE MIB Index
51.49%

Compare To: GHC.MI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GHC.MI

View More

Valuation Measures

Annual
As of 1/17/2025
  • Market Cap

    449.28M

  • Enterprise Value

    644.71M

  • Trailing P/E

    27.97

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    1.43

  • Enterprise Value/EBITDA

    9.32

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.52%

  • Return on Assets (ttm)

    4.24%

  • Return on Equity (ttm)

    7.65%

  • Revenue (ttm)

    431.14M

  • Net Income Avi to Common (ttm)

    23.8M

  • Diluted EPS (ttm)

    0.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.38M

  • Total Debt/Equity (mrq)

    63.83%

  • Levered Free Cash Flow (ttm)

    46.17M

Research Analysis: GHC.MI

View More

Company Insights: GHC.MI

Research Reports: GHC.MI

View More

People Also Watch